Anna Salim, CFA

Xampla is creator of natural materials for commercial applications. In the Autumn of 2023, Xampla launched its new brand, Morro. Morro brings to the market sustainable, next-generation materials that are plant-based, strong and fully biodegradable. Morro Edible Film, Morro Soluble Film, Morro Coating and Morro Micro can be used to eliminate the need for the most polluting plastics. Utilising our technology to do things plastic never could, Morro Nutri offers a cutting-edge solution for vitamin fortification. Look out for the Morro marque on packaging. We all want to live without harming the planet. Morro makes it simple.

Qureight is a clinical data analytics company based in Cambridge UK. Working with healthcare institutions, technology companies and the pharmaceutical industry our platform allows the realisation of new endpoints in clinical data.

ENGAGE XR Holdings PLC is a multi-award winning virtual reality (VR) software company dedicated to changing how people meet, collaborate and learn through the ENGAGE platform. Dual listing on the London Stock Exchange AIM and Irish Stock Exchange ESM, ENGAGE is at the forefront of virtual communications. In November 2022, ENGAGE launched ENGAGE LINK a business-focused metaverse platform designed for corporations, professionals, education organizations, and event organizers to create their own virtual worlds, provide services directly to their clients and allow them to engage with employees, customers and suppliers. ENGAGE LINK is an evolution of ENGAGE XR’s successful immersive communications platform which has grown to serve more than 180 commercial customers over the three years since its launch in 2019. ENNGAGE LINK enables clients to develop new business models and create revenue opportunities through the publicly explorable persistent metaverse world where users can socialize with other professionals and visit client-made virtual locations.

We are Out.In Collective. We are here to change the face of delivery food. We cook in kitchens, not factories. We care about produce, people and our planet. We know where our ingredients come from. We treat our drivers with respect. We reject waste and excess packaging. We are Out.In The best of eating out. The best of staying in.

Launched in May 2016, KIDLY is an online kids’ lifestyle store for 0-5s, founded by ASOS’s first employee & e-commerce director, James Hart. We offer our very own KIDLY Label - a collection of quality, sustainable clothing, homewares & toys - alongside an edit of complementary third-party children’s brands. Everything’s wrapped up in an inspiring & easy-to-shop experience from a mobile-first platform, so you can easily browse one-handed on your phone at 3am while holding a small sleep thief. (Yes, we’ve been there.) The KIDLY mission is to connect everyone (with 0-5s in their lives) with the world’s best kids’ products, and our point of difference is that we only sell design-led & genuinely useful things that complement parents own sense of style.

At Savyll, we believe our range of alcohol-free cocktails can unite every diverse celebration. Join us on our journey to help the world #celebratedifferent

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENE™ is headquartered in Oxford, UK. For additional information, please visit our website.

Airportr is an airline-integrated technology platform that provides smart baggage solutions for departing and arriving passengers. We connect airlines, airports, and people, to unlock the contactless journeys the industry is determined to create - by helping customers to travel bag-free, avoid queues, and eliminate the need to interact with SSBDs or agents at the airport. Without bags, 67% of Airportr’s users switch from vehicles to public transport when traveling to or from the airport. By taking baggage out of the equation, were transforming customer journeys, and making airlines and airports more efficient. When departing, friendly, vetted couriers come to the customers’ doorstep, validate travel documents, secure bags, and transport them to the airport where they’re checked-in for their flight. When arriving, agents collect baggage directly from the carousel, clear it through Customs, and deliver it to the final destination. Customers are kept up-to-date at every step via email, SMS, and a personalized tracking portal. Over 150,000 travellers in the UK alone trust us to help them travel stress-free. We’re building a network of connected airports, by deploying our technology to supply chain partners around the world. This means our services can be sold to customers on an ever-increasing proportion of journeys, continually increasing the addressable market. Our Global Strategic Partnership with Swissport, provider of ground handling services operating in 270+ airports, will see Airportr services deployed to new territories in 2024 and beyond. Find out more about how AirPortr can help your business at https://airportr.com/en/b2b

HonestBrew is the UKs leading online craft beer retailer, sourcing and stocking the best craft beers from independent breweries around the world. We stock a changing range of the best beers from around the world including breweries such as Beavertown, Cloudwater, Siren and more. Pick’n’mix your own selection of beers, grab a curated mixed case or enjoy regular deliveries with our Honesty Box subscription service. Get started at: honestbrew.co.uk Looking for trade beers or office beers for the team? Head to: corporate.honestbrew.co.uk

We believe home cooking is important. But in today’s busy world, it’s often the first thing to go. With Gousto, you choose recipes you’d like to cook and ta-dah! We deliver the perfectly measured ingredients. Skip the supermarket queue, and create delicious meals to share with those you love. The story so far: Timo (our founder) fondly remembers the family dinners of his childhood, evenings filled with laughter, conversation and new flavours. That’s why he created Gousto, to help today’s busy families come together over a good home-cooked meal. Rated 5 out of 5 by The Sunday Telegraph and ‘Best Buy’ by Independent.co.uk. We’re also one of the fastest-growing companies in the UK. We’ve built an incredible team of passionate, visionary people who are driving the business forward at speed. Sound like you? Get in touch.

Founded in 2011, Zappar is a pioneering UK technology company focused on enhancing and assisting the human experience through cutting-edge computer vision to deliver greater immersion, interaction and accessibility. Zappar’s ecosystem includes; Zapworks, a complete XR platform for deploying rich 3D experiences to the web, including AR, VR and WebXR across handsets and headsets, Zapbox, the world’s most affordable mixed reality headset and Studio Z, an award-winning immersive production studio, delivering best-in-class campaigns across Web3D, AR, VR and WebXR, DOOH and mobile games. More recently, Zappar launched Zapvision to make access to information on product packaging a basic human right by providing brands with a single Accessible QR code solution. This unique combination of solutions under one roof enables businesses to scale immersive experiences more affordably across different use cases, teams and devices. Partners include Nestle, Unilever, Pfizer, H&M, Disney, PwC, AstraZeneca, LEGOLAND, PepsiCo, Mondelez, Atlanta United and many more.

BiVictriX is an emerging drug discovery and development company generating a pioneering new class of next-generation anti-cancer therapeutics which exhibit superior selectivity towards the cancer. Existing antibody-based approaches have shown considerable therapeutic benefit in a number of cancer indications, however the wider application of these drugs to more challenging settings is limited by the shared expression of the targeted antigens on healthy tissues. Thus leading to debilitating and sometimes fatal toxic side-effects associated with treatment. The lack of true cancer specificity seen with existing platforms has resulted in many antibody-based therapeutics being removed from the clinic and is one of the major factors limiting the development of this otherwise promising therapeutic class. BiVictriXs Bi-Cygni therapeutics are engineered to selectively target unique cancer-specific twin antigen fingerprints, which are largely absent from healthy cells. The Bi-Cygni approach links the Companys in-house panel of cancer-restricted twin antigen fingerprints to generate the next generation of bispecific ADC therapeutics with enhanced therapeutic index, across a broad range of malignant indications. The Companys initial focus is on the generation of Bi-Cygni Antibody Drug Conjugates (ADCs), with future plans to expand the technology to other therapeutic modalities (Cell engagers and CAR-T).

C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‑leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD to reach multiple value inflexion points since IPO. Website: www.c4xdiscovery.com Twitter: @C4XDiscovery

Cohort plc is an AIM listed parent company of six innovative, agile and responsive businesses operating in defence and related markets. It aims to add real value through the experience and contacts of its senior team while providing a light-touch but effective governance framework. Its objective is to deliver value to shareholders through its six operating subsidiaries: Chess Dynamics, EID, ELAC SONAR, MASS, MCL and SEA. Cohort was founded on the principle that small and medium sized businesses can prosper by being part of a larger group, where they can benefit from financial oversight, management support and the exchange of information and practices. Cohort aims to achieve this while preserving the high growth potential of innovative independent businesses.

Xampla is creator of natural materials for commercial applications. In the Autumn of 2023, Xampla launched its new brand, Morro. Morro brings to the market sustainable, next-generation materials that are plant-based, strong and fully biodegradable. Morro Edible Film, Morro Soluble Film, Morro Coating and Morro Micro can be used to eliminate the need for the most polluting plastics. Utilising our technology to do things plastic never could, Morro Nutri offers a cutting-edge solution for vitamin fortification. Look out for the Morro marque on packaging. We all want to live without harming the planet. Morro makes it simple.

LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The companys novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.

IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntingtons and other rare diseases.

Oxford Innovation Finance is the home of OION (Oxford Investment Opportunity Network) and the Oxford Innovation EIS Growth Fund. We connect the UK’s most ambitious science and technology startups with the investment they need to drive innovation, scale their businesses, and make a positive impact. For over 30 years, we’ve been at the heart of the UK’s startup ecosystem—carefully matching high-potential companies with experienced investors who offer more than just capital. Through our regular Showcase events—held both in-person and online—we provide a platform for founders to pitch their businesses to a curated audience of angel investors. Most opportunities qualify for SEIS or EIS tax relief, helping to reduce risk and enhance returns for investors. Oxford Innovation Finance is authorised and regulated by the Financial Conduct Authority - reference number 564525.

Qureight is a clinical data analytics company based in Cambridge UK. Working with healthcare institutions, technology companies and the pharmaceutical industry our platform allows the realisation of new endpoints in clinical data.